Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer
University of Wisconsin, Madison
University of Wisconsin, Madison
Providence Health & Services
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
Thomas Jefferson University
Grand Hôpital de Charleroi
University of Arkansas
Oslo University Hospital
Genexine, Inc.
Hoffmann-La Roche
Roswell Park Cancer Institute
Hoffmann-La Roche
University of Kansas Medical Center
Institut fuer Frauengesundheit
AbbVie
Merck Sharp & Dohme LLC
GBG Forschungs GmbH
ETOP IBCSG Partners Foundation
Russian Academy of Medical Sciences